Recent Company News

• 04:06 PM ET Nov 02, 2026
  

  Orexo finalises 9-for-1 rights issue; to raise ~SEK253M at SEK0.80/sh (SEK 4.21, 0.00)

• 06:01 AM ET Oct 29, 2026
  

  Orexo announces FDA acceptance of IZIPRY NDA resubmission for review (SEK 5.44, +0.73)

• 04:51 AM ET Oct 26, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (72 total)

• 04:49 AM ET Oct 23, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (94 total)

• 09:25 AM ET Oct 22, 2026
  

  Transcript Intelligence: Orexo Q3 Earnings Themes

• 09:25 AM ET Oct 22, 2026
  

  Transcript Intelligence: Orexo Q3 Earnings Guidance

• 09:25 AM ET Oct 22, 2026
  

  Transcript Intelligence: Orexo Q3 Earnings Q&A

• 04:34 AM ET Oct 22, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:54 AM ET Oct 22, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (100 total)

• 01:20 AM ET Oct 22, 2026
  

  Orexo reports Q3 EPS (SEK3.36) vs FactSet (SEK2.10) [1 est] (SEK 5.35, 0.00)